TMCnet

Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry

(k) package submission on track for calendar H2 2026, targeting planned entry into multi-billion-dollar U.S. drug screening market NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions ...
Nasdaq

BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD.

KUALA LUMPUR, MALAYSIA, June 04, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS; the “Company”) today announced that it entered into a Business Combination Agreement (“BCA”) with ...
Business Wire

Windfall Bio Raises $9 Million Seed Funding to Launch First-Ever Methane-to-Organic Fertilizer Solution

MENLO PARK, Calif.--(BUSINESS WIRE)--Windfall Bio, an agtech/climate startup focused on transforming dilute methane emissions into value-add products, announced today the close of a $9 million seed ...
Business Wire

Windfall Bio Appoints Chief Operating Officer and VP of Engineering to Bring First-Ever Methane-to-Organic Fertilizer Solution to Market

MENLO PARK, Calif.--(BUSINESS WIRE)--Windfall Bio, an agtech/climate startup focused on transforming dilute methane emissions into value-add products, today announced it has established a team of ...

Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8013, an Antibody Drug Conjugate Targeting CD25 for the Treatment of Advanced Solid Tumors

Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical study evaluating BAT8013, an antibody drug conjugate (ADC ...